Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Mechanisms of persistence of Clostridioides difficile in the intestinal mucosa

Award Number: R01AI177842
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 04/25/2024
PERIOD OF PERFORMANCE END DATE: 02/28/2029

Group Awards By:

View Award Description

Mechanisms of persistence of Clostridioides difficile in the intestinal mucosa - PROJECT SUMMARY/ABSTRACT Clostridioides difficile is a Gram-positive, spore forming and strictly anaerobic and pathogenic bacterium that is the leading cause of antibiotic-associated diarrhea worldwide. C. difficile infections (CDI) are highly contagious, difficult to treat and prevent recurrence of the infection. There are several critical gaps in our current knowledge of the molecular mechanisms of persistence of C. difficile spores during CDI-treatment that lead to recurrence of the infection. Our long-term goals are to elucidate how C. difficile spores interact with the intestinal mucosa to facilitate spore-persistence and how these interactions lead to disease recurrence. Our previous studies revealed that C. difficile spores internalized and adhered in intestinal epithelial cells act as a reservoir for the recurrence of the infection. These results lead to our central hypothesis: that C. difficile spores combine intracellular and adherence mechanisms to persist in the intestinal mucosa during infection and treatment, to drive disease recurrence. Towards this hypothesis, we found that C. difficile spores internalize into intestinal epithelial cells (IECs). During vancomycin treatment of C. difficile-infected mice, we observed in ileal, cecum, and colonic samples, significant persistence of adhered and intracellular C. difficile spores. We observed that C. difficile spores interact, in a concentration dependent manner, with the extracellular matrix proteins fibronectin (Fn) and vitronectin (Vn), and uses them as molecular bridges to gain entry into IECs in an a5b1 and avb1 integrin- dependent manner. The spore surface protein, BclA3, is essential for spore entry into IECs via the Fn/Vn-integrin pathway. BclA3 contributes to disease recurrence, apparently by enhancing spore adherence to the intestinal mucosa. Administration of the cholesterol-sequestering agent, nystatin, strongly attenuated spore entry into IECs in an ileal and colonic loop mouse model, while administration of nystatin during vancomycin treatment of C. difficile-infected mice diminished disease recurrence in mice. Our results also show that E-cadherin interacts with C. difficile spores and plays a role in spore-adherence to IECs, and that E-cadherin-mediated spore- adherence to IECs is enhanced by toxin-mediated damage, which may also play a role in recurrence of CDI. Guided by our strong preliminary data, we propose to pursue three Specific Aims to characterize the mechanism underlying the interactions between C. difficile spores and the intestinal mucosa that contribute to recurrence of the infection: (1) Dissect the mechanism of internalization of C. difficile spores into intestinal epithelial cells; (2) Determine the role of adhered and intracellular spores in C. difficile persistence and disease recurrence; (3) Investigate the impact of toxins in E-cadherin-mediated C. difficile persistence and infection recurrence. Completion of these aims may expose novel targets for decolonization, therapeutics, and vaccine strategies to combat this pathogen.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $596,335 )
2026	2026	TEXAS A & M UNIVERSITY	400 HARVEY MITCHELL PKY S STE 300	COLLEGE STATION	TX	77845	BRAZOS	USA	Allergy and Infectious Diseases Research	000	3	2/13/2026	NON-COMPETING CONTINUATION	$596,335
														Subtotal = $596,335

Issue Date FY: 2025 ( Subtotal = $624,894 )
2025	2025	TEXAS A & M UNIVERSITY	400 HARVEY MITCHELL PKY S STE 300	COLLEGE STATION	TX	77845	BRAZOS	USA	Allergy and Infectious Diseases Research	000	2	3/7/2025	NON-COMPETING CONTINUATION	$624,894
														Subtotal = $624,894

Issue Date FY: 2024 ( Subtotal = $681,637 )
2024	2024	TEXAS A & M UNIVERSITY	400 HARVEY MITCHELL PKY S STE 300	COLLEGE STATION	TX	77845	BRAZOS	USA	Allergy and Infectious Diseases Research	001	1	6/7/2024	NEW	$68,164
2024	2024	TEXAS A & M UNIVERSITY	400 HARVEY MITCHELL PKY S STE 300	COLLEGE STATION	TX	77845	BRAZOS	USA	Allergy and Infectious Diseases Research	000	1	4/25/2024	NEW	$613,473
														Subtotal = $681,637

Grand Total All Awards = $1,902,866

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Mechanisms of persistence of Clostridioides difficile in the intestinal mucosa

Award Number: R01AI177842

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 04/25/2024

PERIOD OF PERFORMANCE END DATE: 02/28/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer